As the docking consequence of refametinib shown in Figure 7a, the non-competitive MEK 1/2 inhibitor refametinib [21,22] binds within a pocket individual from, but next to the Mg-ATP molecule site

As the docking consequence of refametinib shown in Figure 7a, the non-competitive MEK 1/2 inhibitor refametinib [21,22] binds within a pocket individual from, but next to the Mg-ATP molecule site. technique of MOE 2015 was completed to recognize the connections of proteins encircling the ligand, and correlating QASR contour maps…